Johnny John - Jun 12, 2023 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role: Senior Vice President Clinical Development and Medical Affairs
Signature: /s/ Gerard Michel, Attorney-in-Fact
Stock symbol: DCTH
Transactions as of: Jun 12, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/21/2023, 09:16 PM
Previous filing: Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCTH	Stock Option (Right to Buy)	Award	$0	+59.8K		$0.00	59.8K	Jun 12, 2023	Common Stock	59.8K	$7.25	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on July 12, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).

Remarks:

Senior Vice President Clinical Development and Medical Affairs